Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nutraceuticals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1261585C enables high-purity isoquercetin via enzymatic hydrolysis. Offers cost reduction and scalable supply for nutraceutical and pharmaceutical manufacturing.
Novel patent CN110452277A details improved niacinamide ribose synthesis. Higher yield, purity, and reduced impurities for reliable supply chain partners.
Novel ionic liquid-mediated Heck coupling for trans-resveratrol. High yield, green process, cost-effective manufacturing for pharmaceutical intermediates.
Discover a novel, high-yield preparation method for Melatonin (CN110818610B) utilizing mild conditions and cost-effective raw materials for scalable pharmaceutical manufacturing.
Patent CN114667346A reveals novel EanB mutants for ergothioneine production. Discover cost-effective enzymatic routes replacing slow fungal fermentation for reliable supply.
Patent CN117587081A reveals enzymatic synthesis for high-purity vitamin E derivatives. Discover cost-effective supply chain solutions and scalable manufacturing.
Patent CN107163014B reveals a novel lanthanide-catalyzed route for icariine. Achieve high purity and scalable manufacturing with our advanced pharmaceutical intermediates supply chain solutions.
Novel three-step synthesis of Dihydroquercetin offers high purity and scalability. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Novel total synthesis of trans-resveratrol via Wittig-Horner. High yield, mild conditions, scalable production for pharmaceutical and nutraceutical applications.
Patent CN109627202B reveals a novel melatonin derivative with 700x solubility. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel catalytic method ensures >98% purity for Vitamin A intermediates. Reduces purification steps and enhances supply chain stability for global buyers.
Novel calcium salt precipitation method reduces solvent use and enhances purity for pharmaceutical intermediates supply chain efficiency and cost reduction significantly.
Novel enzymatic route for high-purity S-Allyl-L-Cysteine from GSAC. Reduces oxidation risks and improves yield for pharmaceutical applications.
Patent CN112724180A reveals a high-yield chemical route for beta-nicotinamide mononucleotide, offering cost reduction and scalable manufacturing for global supply chains.
Patent CN101891595A details a cost-effective chemical synthesis of hydroxytyrosol using 3,4-dihydroxybenzaldehyde, offering scalable production and high purity for pharmaceutical applications.
Advanced synthesis of Nicotinamide Riboside via mild deacetylation. Patent CN112028954B offers high purity, scalable NAD+ precursor manufacturing with reduced safety risks.
Novel copper-catalyzed decarboxylation route for high-purity resveratrol and pterostilbene intermediates. Reduces steps and eliminates protection groups for cost-effective manufacturing.
Patent CN118028403A reveals high-purity NMN synthesis via immobilized enzyme. Offers significant cost reduction and supply chain reliability for nutraceutical manufacturers.
Patent CN110437275A reveals a high-purity Choline Glycerophosphate synthesis route offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116102502A reveals a high-yield 4-step synthesis for ergothioneine. Discover cost-effective manufacturing and scalable supply chain solutions for this potent antioxidant.